# Preemptive Lung Impedance-guided Therapy of Evolving Acute Heart Failure in Acute Myocardial Infarction Patients

> **NCT01264159** · NA · TERMINATED · sponsor: **Hillel Yaffe Medical Center** · enrollment: 70 (actual)

## Conditions studied

- Acute Heart Failure

## Interventions

- **DEVICE:** Lung impedence-guided therapy
- **OTHER:** Usual treatment of patients with developing acute heart failure

## Key facts

- **NCT ID:** NCT01264159
- **Lead sponsor:** Hillel Yaffe Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-01-01
- **Primary completion:** 2015-01-01
- **Final completion:** 2015-07-01
- **Target enrollment:** 70 (ACTUAL)
- **Why stopped:** The principle investigator decided to change the protocol
- **Last updated:** 2020-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01264159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01264159, "Preemptive Lung Impedance-guided Therapy of Evolving Acute Heart Failure in Acute Myocardial Infarction Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01264159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*